Spain plans nanomedical technology research & development line, tender in 2007
This article was originally published in Clinica
Executive Summary
The Spanish government's healthcare research institute, the Instituto de Salud Carlos III (ISC), is to establish a research "line" dedicated specifically to nanomedical technologies. The initiative, which will be put out to public tender in 2007, will seek to build on the EU's nanotech R&D commitment, as set out in the FP7 framework programme.
You may also be interested in...
Sage’s Dalzanemdor Prospects In Doubt After First Mid-Stage Readout
Dalzanemdor (SAGE-718) showed no difference from placebo in a Phase II Parkinson’s disease study, raising concerns about readouts later this year in Huntington’s and Alzheimer’s diseases.
Behavioral Health Company Two Chairs Secures $72M In Equity And Debt Infusion
Two Chairs, which uses algorithms to match the right therapists with patients, secured $72m in investment to expand its business.
Teva Says The Time Is Right For Two Big Immunology Biosimilar Launches
US market access senior VP Tom Rainey talks to Scrip about the upcoming launches of biosimilar versions of Humira and Stelara.